HYPER IGE SYNDROME FROM STAT3 MUTATION

Clinical trials for HYPER IGE SYNDROME FROM STAT3 MUTATION explained in plain language.

Never miss a new study

Get alerted when new HYPER IGE SYNDROME FROM STAT3 MUTATION trials appear

Sign up with your email to follow new studies for HYPER IGE SYNDROME FROM STAT3 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First trial tests repurposed drug for rare immune disorder

Disease control Recruiting now

This study is testing if baricitinib, a drug used for other immune conditions, is safe for people with Job syndrome who also have lupus-like disease or a severe skin rash (atopic dermatitis). It will enroll about 20 participants aged 12 and older. The main goal is to check for si…

Matched conditions: HYPER IGE SYNDROME FROM STAT3 MUTATION

Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

HYPER IGE SYNDROME FROM STAT3 MUTATION

Get alerted when new HYPER IGE SYNDROME FROM STAT3 MUTATION trials appear

First trial tests repurposed drug for rare immune disorder